Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy

Oncologist - United States
doi 10.1634/theoncologist.10-90003-30
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Hormone-Refractory Prostate Cancer

English

Therapeutic Approach to Hormone-Refractory Prostate Cancer

Oncology & Hematology Review (US)
2007English

Low-Dose Docetaxel in Combination With Dexamethasone for Hormone-Refractory Prostate Cancer

Japanese Journal of Urology
Urology
2011English

BCL-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated With Taxane-Based Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

CS4 Bone Lesions in Hormone Refractory Prostate Cancer (HRPC)

Japanese Journal of Urology
Urology
2006English

Prostate Cancer Related Haemophagocytic Syndrome: Successful Treatment With Chemotherapy

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Treatment of Hormone‐Resistant Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Taxane Chemotherapy for Hormone-Naïve Prostate Cancer With Its Expanding Role as Breakthrough Strategy

Frontiers in Oncology
Cancer ResearchOncology
2016English

Palliative Radiotherapy for Local Progression of Hormone Refractory Stage D2 Prostate Cancer

Japanese Journal of Urology
Urology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy